Delivery Order SPE2DB22D1202-SPE2DB25FVAV4

Award Date 5/27/25
Potential Completion Date 5/28/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,817.10 firm-fixed-price delivery order is for the supply of PEDVAXHIB vaccine vials. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $1,752.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of PEDVAXHIB vaccine vials, with an ultimate completion date of September 18, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, worth $5,687.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEDVAXHIB vaccine vials (0.5ML) and has a completion date of February 6, 2025. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEDVAXHIB VACCINE VIAL 0.5ML, with a ceiling value of $5,557.80 and a period of performance through December 17, 2024. The contract is a Firm Fixed Price arrangement, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of the PEDVAXHIB vaccine vial 0.5ML to the Defense Logistics Agency (DLA). The $1,718.45 firm-fixed-price contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of July 27, 2023. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award is for the delivery of PEDVAXHIB VACCINE VIAL 0.5ML to the Defense Logistics Agency (DLA). The $1,752.30 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of September 25, 2023 and was awarded on September 22, 2023. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of PEDVAXHIB VACCINE VIAL 0.5ML to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that serves as a prime contractor for the U.S. government. The contract has a ceiling value of $7,758.87 and is a Firm Fixed Price Delivery Order with a completion date of June 25, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger...
This federal contract award from the Defense Logistics Agency (DLA) is a $2,379.46 firm fixed-price delivery order for the PEDVAXHIB vaccine vial (0.5 ml) placed with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has an ultimate completion date of October 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $2,377.16 contract is for the delivery of PEDVAXHIB vaccine vials to support military treatment programs and facilities. This award is issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to...
This federal contract award is for the PEDVAXHIB vaccine vial 0.5ML, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,362.66 and a performance period through May 21, 2025. The contract is not set aside for any special business type. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FVAV4
    Delivery Order

This federal contract award is a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide PEDVAXHIB vaccine vials 0.5 mL to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,231.40 and is a firm fixed-price contract with a completion date of May 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026 to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 8/31/25, 12:58 AM